HCA - HCA Healthcare shares gain 3% as results tops forecast; 2021 outlook raised

HCA Healthcare (HCA) announces results for Q1 ended March 31, 2021.Revenues increased 8.7% Y/Y to approx. $14B, beating analyst expectations of $13.63B.Net income and EPS rose 145% individually to $1.4B and $4.14, respectively. EPS came in above consensus of $3.31.For Q1, Adjusted EBITDA increased 44.6% to $3.1B vs. prior year.Cash flows from operating activities jumped 104% to ~2B over prior year.Same facility admissions declined 4.2% and same facility equivalent admissions declined 6.5% in Q1, compared to the prior year period.Same facility revenue per equivalent admission increased 16.6% Y/Y due to increases in acuity of patients treated and favorable payer mix.HCA Board of Directors declared a quarterly cash dividend of $0.48 per share.The company revised guidance ranges from Q4 2020 release.Outlook for FY 2021 Revenues is increased to $54.0B to $55.5B from previous range of $53.5B to $55.5B, consensus $54.65B.Non-GAAP EPS guidance is raised to $13.30 to $14.30 from prior guidance

For further details see:

HCA Healthcare shares gain 3% as results tops forecast; 2021 outlook raised